Stock Report

Download full stock data and analysis for free Last Updated: 29-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Sudeep Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SUDEEPPHRM | BSE: 544619

₹1,138.80

up-down-arrow ₹-26.10 (-2.24%)

As on 28-Sep-2026IST

Market cap

info icon

₹12,857 Cr

Revenue (TTM)

info icon

₹676 Cr

P/E Ratio

info icon

70.4

P/B Ratio

info icon

13.9

Div. Yield

info icon

0.1 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -13.20 26.70 23.56 14.42 24.45
EBIT -13.29 25.33 12.00 36.24 38.68
Net Profit -17.04 31.62 19.80 40.89 39.21
EPS -17.04 13.31 50.65 33.60 34.84
Book Value -- -- 54.92 50.38 46.07
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 35.3928.7232.1832.3835.94
Net Margin info 27.5422.0526.0625.9827.13
Return on equity info 25.7234.5022.7225.3732.76
Return on Capital info 29.4736.43--28.5035.83
Return on Assets info 18.1420.7831.2518.4322.55
Debt to Equity (x) info ----0.040.170.27

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
28.50
35.83
48.76
33.22
Peer Median
--
14.03
16.46
15.49
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

22.72

Higher than Peers by 12.78

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
22.72
25.37
32.76
45.98
32.24
Peer Median
9.94
13.45
13.87
14.72
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

31.25

Higher than Peers by 23.71

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
31.25
18.43
22.55
28.54
16.33
Peer Median
7.54
7.94
8.04
7.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

32.18

Higher than Peers by 22.84

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
32.18
32.38
35.94
37.77
19.18
Peer Median
9.34
21.31
10.05
10.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

26.06

Higher than Peers by 16.71

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
26.06
25.98
27.13
28.62
14.22
Peer Median
9.35
11.88
9.11
6.78
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
28.90
28.51
30.96
16.38
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

23.56

Higher than Peers by 17.17

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
23.56
27.94
9.30
7.12
24.99
Peer Median
6.38
15.92
7.17
10.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

12.00

Higher than Peers by 13.03

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
12.00
15.28
4.01
110.90
30.69
Peer Median
-1.03
24.76
12.05
6.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

19.80

Higher than Peers by 10.76

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
19.80
25.63
4.16
113.71
24.23
Peer Median
9.04
24.25
22.15
27.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

50.65

Higher than Peers by 48.59

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
50.65
7.28
4.01
113.71
24.24
Peer Median
2.05
26.11
8.80
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
79.97
37.86
59.45
36.70
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.04

Higher than Peers by 0.02

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
0.04
0.17
0.27
0.21
0.37
Peer Median
0.02
0.17
0.03
0.05
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
0.12
0.17
0.15
0.23
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.09

Higher than Peers by 0.56

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
3.09
3.09
2.43
2.01
1.35
Peer Median
2.53
2.23
2.20
1.93
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.02

Higher than Peers by 0.24

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
2.02
2.02
1.69
1.53
0.93
Peer Median
1.78
1.82
1.72
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

30.94

Higher than Peers by 20.71

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
30.94
27.82
27.49
37.92
15.87
Peer Median
10.23
11.31
12.28
12.45
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

33.68

Higher than Peers by 7.11

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
33.68
35.43
36.92
31.48
21.86
Peer Median
26.57
30.82
26.23
23.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.15

Higher than Peers by 0.48

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
1.15
0.69
0.85
0.98
1.12
Peer Median
0.67
0.72
0.74
0.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
115.16
114.95
94.68
85.40
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
96.15
68.03
54.67
45.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
106.08
133.44
100.79
68.31
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
--
105.23
49.53
48.56
62.87
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

70.40

Higher than Peers by 15.15

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
70.40
38.70
--
--
--
Peer Median
55.24
58.51
39.17
40.74
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

13.92

Higher than Peers by 9.18

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
13.92
7.57
--
--
--
Peer Median
4.74
4.83
3.61
3.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.13

No difference

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
0.13
0.25
--
--
--
Peer Median
0.13
0.12
0.19
0.20
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

49.24

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
49.24
26.75
0.48
0.33
0.74
Peer Median
--
47.26
28.79
25.41
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

12,857

Higher than Peers by 6,727

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Sudeep Pharma
12,857
6,691
--
--
--
Peer Median
6,130
6,178
3,944
2,959
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...